| 2019-03-26 | Sale | Aldeyra Therapeutics, Inc. ALDX | director | 193,486 0.7373% | $10.01 | $1.94M | -40.37% | |
| 2019-03-04 | Sale | Veracyte, Inc. VCYT | director | 854,302 2.0241% | $20.21 | $17.27M | +23.31% | |
| 2019-03-01 | Sale | Veracyte, Inc. VCYT | director | 550,000 1.3538% | $20.45 | $11.25M | +26.61% | |
| 2019-02-28 | Sale | Veracyte, Inc. VCYT | director | 700,000 1.7251% | $20.50 | $14.35M | +26.32% | |
| 2018-08-01 | Sale | Veracyte, Inc. VCYT | director | 240,000 0.6192% | $10.85 | $2.6M | +66.94% | |
| 2018-07-31 | Sale | Veracyte, Inc. VCYT | director | 760,000 1.9661% | $10.82 | $8.22M | +66.2% | |
| 2017-05-16 | Sale | Veracyte, Inc. VCYT | director | 4,452 0.013% | $8.08 | $35,972 | -16.83% | |
| 2013-07-01 | Esperion Therapeutics, Inc. ESPR | 10 percent owner | 571,428 3.7236% | $14.00 | $8M | +8.67% | ||
| 2011-06-02 | Sale | Alimera Sciences, Inc. ALIM | 10 percent owner | 13,828 0.044% | $8.04 | $111,177 | -53.11% | |
| 2010-04-27 | Alimera Sciences, Inc. ALIM | 10 percent owner | 756,056 3.1079% | $11.00 | $8.32M | -17.39% | ||
| 2006-12-12 | Sale | Vanda Pharmaceuticals Inc. VNDA | 10 percent owner | 25,800 0.1648% | $25.62 | $660,996 | -19.11% |